Literature DB >> 28147277

Regulation of Serine-Threonine Kinase Akt Activation by NAD+-Dependent Deacetylase SIRT7.

Jia Yu1, Bo Qin2, Fengying Wu3, Sisi Qin1, Somaira Nowsheen4, Shan Shan5, Jacqueline Zayas4, Huadong Pei6, Zhenkun Lou7, Liewei Wang8.   

Abstract

The Akt pathway is a central regulator that promotes cell survival in response to extracellular signals. Depletion of SIRT7, an NAD+-dependent deacetylase that is the least-studied sirtuin, is known to significantly increase Akt activity in mice through unknown mechanisms. In this study, we demonstrate that SIRT7 depletion in breast cancer cells results in Akt hyper-phosphorylation and increases cell survival following genotoxic stress. Mechanistically, SIRT7 specifically interacts with and deacetylates FKBP51 at residue lysines 28 and 155 (K28 and K155), resulting in enhanced interactions among FKBP51, Akt, and PHLPP, as well as Akt dephosphorylation. Mutating both lysines to arginines abolishes the effect of SIRT7 on Akt activity through FKBP51 deacetylation. Finally, energy stress strengthens SIRT7-mediated effects on Akt dephosphorylation through FKBP51 and thus sensitizes cancer cells to cytotoxic agents. These results reveal a direct role of SIRT7 in Akt regulation and raise the possibility of using the glucose analog 2-deoxy-D-glucose (2DG) as a chemo-sensitizing agent.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Akt signaling pathway; SIRT7; breast cancer; chemo-sensitivity

Mesh:

Substances:

Year:  2017        PMID: 28147277      PMCID: PMC5298804          DOI: 10.1016/j.celrep.2017.01.009

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  56 in total

Review 1.  Are sirtuins viable targets for improving healthspan and lifespan?

Authors:  Joseph A Baur; Zoltan Ungvari; Robin K Minor; David G Le Couteur; Rafael de Cabo
Journal:  Nat Rev Drug Discov       Date:  2012-06-01       Impact factor: 84.694

2.  Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors.

Authors:  M Andjelković; T Jakubowicz; P Cron; X F Ming; J W Han; B A Hemmings
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  A divergent role of the SIRT1-TopBP1 axis in regulating metabolic checkpoint and DNA damage checkpoint.

Authors:  Tongzheng Liu; Yi-Hui Lin; Wenchuan Leng; Sung Yun Jung; Haoxing Zhang; Min Deng; Debra Evans; Yunhui Li; Kuntian Luo; Bo Qin; Jun Qin; Jian Yuan; Zhenkun Lou
Journal:  Mol Cell       Date:  2014-11-13       Impact factor: 17.970

4.  PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth.

Authors:  Tianyan Gao; Frank Furnari; Alexandra C Newton
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

5.  Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth.

Authors:  David J Mulholland; Linh M Tran; Yunfeng Li; Houjian Cai; Ashkan Morim; Shunyou Wang; Seema Plaisier; Isla P Garraway; Jiaoti Huang; Thomas G Graeber; Hong Wu
Journal:  Cancer Cell       Date:  2011-05-27       Impact factor: 31.743

6.  Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription.

Authors:  Ethan Ford; Renate Voit; Gregory Liszt; Cornelia Magin; Ingrid Grummt; Leonard Guarente
Journal:  Genes Dev       Date:  2006-04-17       Impact factor: 11.361

7.  Altered expression of SIRT gene family in head and neck squamous cell carcinoma.

Authors:  Chi-Chih Lai; Pai-Mei Lin; Sheng-Fung Lin; Cheng-Hsien Hsu; Hsin-Ching Lin; Ming-Luen Hu; Cheng-Ming Hsu; Ming-Yu Yang
Journal:  Tumour Biol       Date:  2013-03-12

8.  Global levels of histone modifications predict prognosis in different cancers.

Authors:  David B Seligson; Steve Horvath; Matthew A McBrian; Vei Mah; Hong Yu; Sheila Tze; Qun Wang; David Chia; Lee Goodglick; Siavash K Kurdistani
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

9.  FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt.

Authors:  Huadong Pei; Liang Li; Brooke L Fridley; Gregory D Jenkins; Krishna R Kalari; Wilma Lingle; Gloria Petersen; Zhenkun Lou; Liewei Wang
Journal:  Cancer Cell       Date:  2009-09-08       Impact factor: 31.743

10.  The direct involvement of SirT1 in insulin-induced insulin receptor substrate-2 tyrosine phosphorylation.

Authors:  Jiandi Zhang
Journal:  J Biol Chem       Date:  2007-09-27       Impact factor: 5.157

View more
  33 in total

1.  DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine.

Authors:  Jia Yu; Bo Qin; Ann M Moyer; Somaira Nowsheen; Tongzheng Liu; Sisi Qin; Yongxian Zhuang; Duan Liu; Shijia W Lu; Krishna R Kalari; Daniel W Visscher; John A Copland; Sarah A McLaughlin; Alvaro Moreno-Aspitia; Donald W Northfelt; Richard J Gray; Zhenkun Lou; Vera J Suman; Richard Weinshilboum; Judy C Boughey; Matthew P Goetz; Liewei Wang
Journal:  J Clin Invest       Date:  2018-04-30       Impact factor: 14.808

2.  Ubiquitin-specific peptidase 7 (USP7)-mediated deubiquitination of the histone deacetylase SIRT7 regulates gluconeogenesis.

Authors:  Lu Jiang; Jiannan Xiong; Junsi Zhan; Fengjie Yuan; Ming Tang; Chaohua Zhang; Ziyang Cao; Yongcan Chen; Xiaopeng Lu; Yinglu Li; Hui Wang; Lina Wang; Jiadong Wang; Wei-Guo Zhu; Haiying Wang
Journal:  J Biol Chem       Date:  2017-06-27       Impact factor: 5.157

3.  Differential gene expression of sirtuins between somatotropinomas and nonfunctioning pituitary adenomas.

Authors:  Isabella P P Grande; Paulo V G H Amorim; Ane Caroline Thé B Freire; Raquel S Jallad; Nina R Musolino; Valter A Cescato; Gilberto O da Silva; Marcello D Bronstein; Ericka B Trarbach
Journal:  Pituitary       Date:  2018-08       Impact factor: 4.107

4.  The epigenetic regulator SIRT7 guards against mammalian cellular senescence induced by ribosomal DNA instability.

Authors:  Silvana Paredes; Maria Angulo-Ibanez; Luisa Tasselli; Scott M Carlson; Wei Zheng; Tie-Mei Li; Katrin F Chua
Journal:  J Biol Chem       Date:  2018-05-04       Impact factor: 5.157

5.  Functional genomics based on germline genome-wide association studies of endocrine therapy for breast cancer.

Authors:  Jacqueline Zayas; Sisi Qin; Jia Yu; James N Ingle; Liewei Wang
Journal:  Pharmacogenomics       Date:  2020-06-16       Impact factor: 2.533

Review 6.  Metabolites as regulators of insulin sensitivity and metabolism.

Authors:  Qin Yang; Archana Vijayakumar; Barbara B Kahn
Journal:  Nat Rev Mol Cell Biol       Date:  2018-10       Impact factor: 94.444

Review 7.  Is nuclear sirtuin SIRT6 a master regulator of immune function?

Authors:  Vinodkumar B Pillai; Mahesh P Gupta
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-12-14       Impact factor: 4.310

Review 8.  The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus.

Authors:  Saikat Dewanjee; Jayalakshmi Vallamkondu; Rajkumar Singh Kalra; Pratik Chakraborty; Moumita Gangopadhyay; Ranabir Sahu; Vijaykrishna Medala; Albin John; P Hemachandra Reddy; Vincenzo De Feo; Ramesh Kandimalla
Journal:  Cells       Date:  2021-05-28       Impact factor: 6.600

Review 9.  SIRT7: a sentinel of genome stability.

Authors:  Ming Tang; Huangqi Tang; Bo Tu; Wei-Guo Zhu
Journal:  Open Biol       Date:  2021-06-16       Impact factor: 6.411

10.  The nonreceptor tyrosine kinase SRMS inhibits autophagy and promotes tumor growth by phosphorylating the scaffolding protein FKBP51.

Authors:  Jung Mi Park; Seung Wook Yang; Wei Zhuang; Asim K Bera; Yan Liu; Deepak Gurbani; Sergei J von Hoyningen-Huene; Sadie Miki Sakurada; Haiyun Gan; Shondra M Pruett-Miller; Kenneth D Westover; Malia B Potts
Journal:  PLoS Biol       Date:  2021-06-02       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.